Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.59B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.04B |
| 3 |
Microsoft
MSFT
|
+$794M |
| 4 |
Home Depot
HD
|
+$512M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$357M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$491M |
| 2 |
Linde
LIN
|
+$373M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$298M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$290M |
| 5 |
Salesforce
CRM
|
+$249M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 56.47% |
| 2 | Technology | 8.38% |
| 3 | Healthcare | 7.46% |
| 4 | Consumer Discretionary | 5.14% |
| 5 | Industrials | 5.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3751
Cathay General Bancorp
CATY
$4.13B
| $1.31M | ﹤0.01% |
40,736
-173,620
| -81% | -$5.51M |
|
|
CHX
3752
DELISTED
ChampionX
CHX
| $1.31M | ﹤0.01% |
42,242
-210,429
| -83% | -$5.79M |
|
|
DICE
3753
CALL
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
| $1.31M | ﹤0.01% |
28,200
-2,000
| -7% | -$69.1K |
|
3754
CALL
NIO
NIO
$10.9B
| $1.31M | ﹤0.01% |
134,900
-49,900
| -27% | -$422K |
|
3755
PUT
American Eagle Outfitters
AEO
$2.83B
| $1.31M | ﹤0.01% |
+110,600
| New | +$1.38M |
|
3756
Codere Online
CDRO
$409M
| $1.3M | ﹤0.01% |
353,499
-44,085
| -11% | -$134K |
|
3757
Accuray
ARAY
$32.7M
| $1.3M | ﹤0.01% |
336,319
-607,632
| -64% | -$2.11M |
|
3758
Cadiz
CDZI
$338M
| $1.3M | ﹤0.01% |
319,845
-369,536
| -54% | -$1.63M |
|
|
CRESY
3759
Cresud
CRESY
$784M
| $1.3M | ﹤0.01% |
+170,870
| New | +$1.12M |
|
3760
CALL
Sunrun
RUN
$2.11B
| $1.3M | ﹤0.01% |
72,600
+5,500
| +8% | +$102K |
|
|
3761
PUT
Sunrun
RUN
$2.11B
| $1.3M | ﹤0.01% |
72,600
+5,500
| +8% | +$102K |
|
3762
State Street SPDR S&P Metals & Mining ETF
XME
$4.74B
| $1.3M | ﹤0.01% |
+25,503
| New | +$1.25M |
|
3763
Telus
TU
$15.2B
| $1.29M | ﹤0.01% |
66,441
-13,328
| -17% | -$268K |
|
|
VTYX
3764
DELISTED
Ventyx Biosciences
VTYX
| $1.29M | ﹤0.01% |
+39,407
| New | +$1.36M |
|
3765
PUT
International Paper
IP
$20.8B
| $1.29M | ﹤0.01% |
40,600
-89,600
| -69% | -$2.94M |
|
|
BERY
3766
PUT
DELISTED
Berry Global Group, Inc.
BERY
| $1.29M | ﹤0.01% |
+21,780
| New | +$1.19M |
|
|
BRT
3767
BRT Apartments
BRT
$273M
| $1.29M | ﹤0.01% |
+64,931
| New | +$1.2M |
|
3768
Angi Inc
ANGI
$204M
| $1.29M | ﹤0.01% |
38,942
+8,689
| +29% | +$243K |
|
3769
PUT
Paycom
PAYC
$10.8B
| $1.28M | ﹤0.01% |
4,000
| – | – |
|
|
SUP
3770
DELISTED
Superior Industries International
SUP
| $1.28M | ﹤0.01% |
356,285
+143,298
| +67% | +$582K |
|
|
FSRX
3771
DELISTED
FinServ Acquisition Corp. II Class A Common Stock
FSRX
| $1.28M | ﹤0.01% |
125,000
| – | – |
|
|
STR
3772
DELISTED
Sitio Royalties
STR
| $1.28M | ﹤0.01% |
+48,688
| New | +$1.25M |
|
3773
POSCO
PKX
$18.2B
| $1.28M | ﹤0.01% |
17,272
+4,918
| +40% | +$358K |
|
3774
Tarsus Pharmaceuticals
TARS
$3.15B
| $1.28M | ﹤0.01% |
70,672
+57,285
| +428% | +$911K |
|
3775
Regal Rexnord
RRX
$10.5B
| $1.28M | ﹤0.01% |
8,294
+5,863
| +241% | +$798K |
|
Similar funds
Israel Englander's Q2 2023 Portfolio in Review
As of Q2 2023, Israel Englander held 7,181 positions worth $203B, up 16% from $174B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Israel Englander's Q2 2023 filing shows 870 new, 2,213 increased, 2,337 reduced and 1,192 closed positions. Its largest new stake was ResMed: 632,015 shares worth $138M. The largest sale was Tesla, an estimated $491M.
By sector, the portfolio is most concentrated in Miscellaneous at 56% of assets, up from 53% a quarter earlier, followed by Technology and Healthcare.
- Israel Englander's largest Q2 2023 buy was ResMed: 632,015 shares worth $138M.
- Israel Englander added most to iShares Core S&P 500 ETF in Q2 2023, an estimated $1.59B increase.
- Israel Englander's biggest Q2 2023 reduction was Tesla, cutting an estimated $491M.
- Israel Englander fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $237M.
- Israel Englander's ten largest holdings make up 26% of its $203B portfolio in Q2 2023.
- Israel Englander opened 870 new positions and closed 1,192 in Q2 2023.
- Israel Englander's portfolio value rose 16% quarter-over-quarter to $203B.
Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.